View on PR Newswire here. Rye Brook, NY - March 20, 2019 – Everyone loves a little friendly competition, especially if the reward is saving lives and keeping families together. The Leukemia & Lymphoma Society (LLS), the world’s largest nonprofit dedicated to fighting blood cancer, knows all too well the devastation cancer causes for families and communities. LLS has kicked off its 30th annu...
Washington, DC (March 13, 2019) – The Leukemia & Lymphoma Society (LLS) is proud to support the Cancer Drug Parity Act, which will remove a key financial barrier that prevents some patients from accessing their prescribed cancer treatments. This bipartisan legislation was reintroduced today in the U.S. House of Representatives by Representative Brian Higgins (D-N.Y.), Representative Brett Guthrie (R-Ky.), Repre...
Rye Brook, N.Y. (Mar. 1, 2019) — As costs for cancer care skyrocket, The Leukemia & Lymphoma Society® (LLS) is putting forward 31 policy recommendations aimed at lowering the cost of cancer care for patients, while protecting access to quality care. Louis J. DeGennaro, Ph.D., LLS president and CEO, issued the following statement regarding the cost of cancer care: “The hig...
(Rye Brook, NY, Jan. 15 2019) – Groundbreaking advances that harness the body’s immune system to attack cancer cells are set to continue, as well as significant focus on new therapies for children with cancer. And expect the revolution to gain steam in cancer treatments moving away from toxic chemotherapy toward genetics-driven targeted therapies, the foundation of precision medicine. This according to L...
Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday: